Pornlada Likasitwatanakul

22PUBLICATIONS
126CO-AUTHORS
Predictive and prognostic markersSolid tumoursMolecular targetsHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Oct 26, 2025
HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer.

Pornlada Likasitwatanakul, Carissa Besonen, Alexander K Tsai

|Oct 16, 2025
Novel MAML2 Fusions in Human Malignancy.

Takefumi Komiya, Kieran Sweeney, Chao H Huang

|Aug 12, 2025
SOX2 utilizes FOXA1 as a heteromeric transcriptional partner to drive proliferation in therapy-resistant prostate cancer.

John T Phoenix, Audris Budreika, Devin A Schmeck

|May 14, 2025
Germline DNA Repair Gene Mutations and Clonal Hematopoiesis (CH) in 24,849 Patients with BRCA-Associated Cancers.

Catherine H Marshall, Ali T Arafa, Ellen Jaeger

|Apr 26, 2025
The Influence of the Germline HSD3B1 Adrenal-Permissive Allele (c.1100 C) on the Somatic Alteration Landscape, the Transcriptome, and Immune Cell Infiltration in Prostate Cancer.

Samuel Kellen, Allison Makovec, Carly D Miller

|Feb 06, 2025
Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancer.

Samuel P Pitzen, Amber N Rudenick, Yinjie Qiu

Pageof 4

Frequent Collaborators

4 joint publications

Andrew Elliott

3 joint publications

Himisha Beltran

3 joint publications

Pedro C Barata

3 joint publications

Scott M Dehm